EyePoint Pharmaceuticals, Inc. (EYPT) Insider Trading

Over the last 3 months, EYPT insiders made 1 open-market buy and 2 sales, a net sale of -$21K (SEC Form 4). Over the last 6 months, 142 institutions increased and 106 reduced their position (13F).

Insider Activity

Sentiment
42/100
Buys (3m)
1
Sells (3m)
2
Net (3m)
-$20.9K
Insiders buyingFirst buy in 2 quarters
Insider trades by month Buys Sells
Jan
Feb
Mar
Apr
Jul
Aug
Context3-month price -65.9%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Aug 18, 2026Zaderej Karen L.directorBuy10,600$4.93
Jul 14, 2026Duker Jay S.director, officer: President and CEOTax8,059$14.72
Jul 14, 2026Duker Jay S.director, officer: President and CEOOption16,667
Jul 2, 2026Ribeiro Ramiroofficer: Chief Medical OfficerOption2,438$8.26
Jul 2, 2026Ribeiro Ramiroofficer: Chief Medical OfficerSell2,438$15.02
Jul 2, 2026Ribeiro Ramiroofficer: Chief Medical OfficerSell2,437$15.00
Jul 2, 2026Ribeiro Ramiroofficer: Chief Medical OfficerOption2,437$8.26
May 27, 2026Elston Georgeofficer: Chief Financial OfficerTax3,627$12.93
May 27, 2026Elston Georgeofficer: Chief Financial OfficerOption7,500
Apr 20, 2026Ribeiro Ramiroofficer: Chief Medical OfficerOption2,437$8.26
Apr 20, 2026Ribeiro Ramiroofficer: Chief Medical OfficerSell2,437$15.00
Mar 16, 2026Duker Jay S.director, officer: President and CEOBuy1,500$13.15
Mar 5, 2026Ribeiro Ramiroofficer: Chief Medical OfficerSell2,438$17.87
Mar 5, 2026Ribeiro Ramiroofficer: Chief Medical OfficerOption2,438$8.26
Feb 18, 2026Ribeiro Ramiroofficer: Chief Medical OfficerSell2,437$15.00
Feb 18, 2026Ribeiro Ramiroofficer: Chief Medical OfficerOption2,437$8.26
Jan 7, 2026Duker Jay S.director, officer: President and CEOOption20,793
Jan 7, 2026Elston Georgeofficer: Chief Financial OfficerOption15,285
Jan 7, 2026Ribeiro Ramiroofficer: Chief Medical OfficerOption29,250$8.26
Jan 7, 2026Elston Georgeofficer: Chief Financial OfficerTax4,487$16.86
Jan 7, 2026Lurker NancydirectorOption75,133
Jan 7, 2026Duker Jay S.director, officer: President and CEOTax10,054$16.86
Jan 7, 2026Ribeiro Ramiroofficer: Chief Medical OfficerSell42,544$17.10
Jan 6, 2026Landis John B.directorGrant40,000$17.48
Jan 6, 2026Lurker NancydirectorOption12,666
Jan 6, 2026Duker Jay S.director, officer: President and CEOGrant331,000$17.48
Jan 6, 2026Sanders Reginald J.directorGrant40,000$17.48
Jan 6, 2026Lurker NancydirectorGrant40,000$17.48
Jan 6, 2026Duker Jay S.director, officer: President and CEOGrant165,000
Jan 6, 2026Duty StuartdirectorGrant40,000$17.48

Source: EYPT SEC Form 4 filings, latest Aug 18, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their EYPT positions over the last 6 months (SEC Form 13F).

Increased
142
New positions
75
Reduced
106
Sold out
23
Largest moves
InstitutionActionSharesFiled
SUVRETTA CAPITAL MANAGEMENT, LLCUnchanged8.3MAug 14, 2026
SUVRETTA CAPITAL MANAGEMENT, LLCIncreased8.3MMay 15, 2026
CORMORANT ASSET MANAGEMENT, LPUnchanged8.3MMay 15, 2026
BlackRock, Inc.Increased7.5MAug 7, 2026
BLACKROCK, INC.Increased7.2MMay 13, 2026
Cormorant Asset Management, LPReduced7.0MAug 14, 2026
FEDERATED HERMES, INC.Increased5.7MAug 12, 2026
FEDERATED HERMES, INC.Reduced5.7MMay 11, 2026
FRANKLIN RESOURCES INCIncreased5.0MMay 13, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Increased4.8MAug 14, 2026
FRANKLIN RESOURCES INCReduced4.8MAug 13, 2026
Commodore Capital LPIncreased4.6MAug 14, 2026
Jupiter Topco LLCNew Position3.8MAug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased3.6MAug 13, 2026
JANUS HENDERSON GROUP PLCIncreased3.6MMay 18, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.